Feng, Ge-hui
Liu, Juan-juan
Wang, Yi-fei
Chen, Yun-shan
Zhao, Ke-hao
Yi, Wen-ting
Yue, Qian-qian
Zeng, Ying
Article History
Received: 16 January 2025
Accepted: 28 January 2026
First Online: 26 March 2026
Declarations
:
: All patients must give informed consent to the investigator prior to participation. All trial patients are informed that all their personal information is confidential and that participants can launch the study at any trial stage. The study is being launched after approval from the China Clinical Trials Center (ChiCTR2300073765) and the Medical Ethics Committee University of South China (2022-USC-HL-226). In case of protocol revision, permission will be sought from the relevant authorities, and all investigators will be given full access to the final trial dataset.
: Not applicable.
: The authors declare no competing interests.